Activities  2015 International Activity Report

Kyrgyzstan has high rates of drug-resistant tuberculosis (DR-TB) and yet many people have difficulty accessing care, particularly in rural areas.

Initial hospitalisation of TB patients is standard practice in the country, but since starting work in Kara-Suu district in Osh province MSF has focused on providing outpatient care to limit the amount of time a patient spends in hospital. This reduces their risk of contracting an infection while in hospital, and improves their adherence to the long and arduous treatment regimen. MSF is providing comprehensive DR-TB services in Kara-Suu district, including early detection, enrolment onto the treatment programme, monthly medical consultations for patients, and social and psychological support. Teams work in three TB clinics in Kara-Suu district, providing drugs and laboratory items and mentoring Ministry of Health staff.

MSF continues to support the diagnosis and treatment of patients with DR-TB in the Kara-Suu hospital, which has a separate ward for those infected. The team also assists with the management of the hospital’s waste, and with infection control.

Teams also carry out around 20 home visits per month for patients who are unable to reach the TB clinics, providing them with their treatment as well as psychological support.

Within the framework of the endTB project, MSF is planning to introduce two new DR-TB drugs, bedaquiline and delamanid, in Kyrgyzstan in 2016. Treatment regimens will be shorter and patients will not have to endure injections.

In 2015, there were 127 DR-TB patients enrolled in MSF’s treatment programme.

Year MSF first worked in the country: 2005.

2015 Key figures
Patients under treatment for  MDR-TB 130
No. staff in 2015 84
2015 Expenditure €2.2 million

Figures from 2015 International Activity Report
and 2015 International Financial Report